NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
Existing Patients For Providers →
(855) 940-4867
Depression is one of the most common mental health conditions in the world, affecting more than 21 million adults in the United States.1 For many people, antidepressants combined with therapy provide meaningful relief. But for a significant portion of people living with depression, medications simply don’t deliver the result that they need.
Two of Greenbrook's leaders, Executive Vice President Cory Anderson and Chief Medical Officer Dr. Geoffrey Grammer, share how Greenbrook is helping to reshape what depression treatment looks like.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.